DURHAM, N.C., Dec. 19, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that Kenneth I. Moch, President and CEO of Chimerix, will present at the 32nd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2014 at 12:30pm PST (3:30pm EST) at the Westin St. Francis Hotel in San Francisco.
Help employers find you! Check out all the jobs and post your resume.
